David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
REGI
1826
DELISTED
Renewable Energy Group, Inc.
REGI
| $3.02M | ﹤0.01% |
137,533
+49,674
| +57% | +$1.28M |
|
1827
GeoPark
GPRK
$630M
| $3.02M | ﹤0.01% |
175,098
+79,048
| +82% | +$1.4M |
|
1828
Smith & Nephew
SNN
$12.3B
| $3.01M | ﹤0.01% |
75,099
-316,761
| -81% | -$12.2M |
|
|
K
1829
PUT
DELISTED
Kellanova
K
| $3M | ﹤0.01% |
55,700
-34,825
| -38% | -$1.86M |
|
1830
Hudbay
HBM
$13.3B
| $3M | ﹤0.01% |
419,236
+280,636
| +202% | +$1.74M |
|
1831
CALL
Yum! Brands
YUM
$42.1B
| $2.99M | ﹤0.01% |
+30,000
| New | +$2.84M |
|
1832
Pathward Financial
CASH
$1.7B
| $2.99M | ﹤0.01% |
151,997
+105,838
| +229% | +$2.31M |
|
1833
Haverty Furniture Companies
HVT
$425M
| $2.99M | ﹤0.01% |
136,563
-353
| -0.3% | -$7.63K |
|
1834
BGC Group
BGC
$5.66B
| $2.99M | ﹤0.01% |
562,297
-295,718
| -34% | -$1.76M |
|
|
BIG
1835
PUT
DELISTED
Big Lots, Inc.
BIG
| $2.98M | ﹤0.01% |
78,500
+5,400
| +7% | +$176K |
|
1836
PUT
Ralph Lauren
RL
$21.6B
| $2.98M | ﹤0.01% |
23,000
-137,600
| -86% | -$16.4M |
|
|
TVPT
1837
DELISTED
Travelport Worldwide Limited
TVPT
| $2.98M | ﹤0.01% |
189,657
-130,177
| -41% | -$2.04M |
|
1838
Vistra
VST
$47B
| $2.98M | ﹤0.01% |
+114,557
| New | +$2.89M |
|
|
RYZ
1839
Ryerson Holding Corp
RYZ
$1.31B
| $2.98M | ﹤0.01% |
348,199
+34,275
| +11% | +$266K |
|
1840
Netflix
NFLX
$339B
| $2.98M | ﹤0.01% |
83,550
-156,870
| -65% | -$5.44M |
|
1841
CALL
DexCom
DXCM
$33.6B
| $2.98M | ﹤0.01% |
100,000
| – | – |
|
|
DESP
1842
DELISTED
Despegar.com
DESP
| $2.97M | ﹤0.01% |
199,551
+164,293
| +466% | +$2.6M |
|
1843
Universal Electronics
UEIC
$57.9M
| $2.97M | ﹤0.01% |
79,919
+30,915
| +63% | +$949K |
|
|
VRS
1844
DELISTED
Verso Corporation
VRS
| $2.97M | ﹤0.01% |
138,521
+33,251
| +32% | +$767K |
|
1845
PUT
Grand Canyon Education
LOPE
$3.88B
| $2.97M | ﹤0.01% |
25,900
-200
| -0.8% | -$20.6K |
|
|
CCI.PRA
1846
DELISTED
Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A
CCI.PRA
| $2.96M | ﹤0.01% |
+2,500
| New | +$2.77M |
|
1847
John Wiley & Sons Class A
WLY
$2.7B
| $2.96M | ﹤0.01% |
66,945
-8,897
| -12% | -$436K |
|
1848
CALL
Crown Holdings
CCK
$13B
| $2.96M | ﹤0.01% |
54,200
+1,500
| +3% | +$77.4K |
|
1849
CALL
Cracker Barrel
CBRL
$1.31B
| $2.96M | ﹤0.01% |
18,300
+5,800
| +46% | +$954K |
|
1850
Oil States International
OIS
$500M
| $2.96M | ﹤0.01% |
174,322
-92,129
| -35% | -$1.56M |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $2.66B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.